We compared changes in cardiopulmonary function during unsedated transnasal small-caliber and transoral conventional EGD in patients aged > 65 years old.

Patients: Between July 2006 and April 2007, we enrolled 240 elderly patients (> 65 years old), who received EGD for their abdominal symptoms and for their annual medical check in the Izumo City General Medical Center, into the prospective comparison study. The first consecutive 120 patients were assigned to the transnasal small-caliber EGD (TN) group and the second consecutive 120 patients to the transoral conventional EGD (TO) group.

Endoscopic procedure: A single experienced endoscopist (M.Y.), certified by the Japan Gastroenterological Endoscopy Society, performed all of the examinations. Patients in the TN group were examined with a small-caliber videoendoscope (EG-530N; Fujinon Toshiba ES Systems Co. Ltd., Tokyo, Japan), 5.9 mm in diameter. Patients in the TO group were examined with a conventional endoscope (GIF-H260; Olympus Medical Systems, Tokyo, Japan), 9.8 mm in diameter. Patients who needed endoscopic biopsy and/or received a time-consuming chromoendoscopic examination were excluded from this study.

Patients in the TO group received throat anesthesia by application of 5 mL 2% lidocaine viscous (Xylocaine viscous; Astra Zeneca, Osaka, Japan) for 5 min. Nasal anesthesia was started in patients in the TN group by spraying a solution of 0.4% lidocaine and 0.5% naphazoline into the nostril. The patients were then instructed to inhale 2% lidocaine jelly (Xylocaine jelly; Astra Zeneca), and a 20 Fr catheter covered with lidocaine jelly was inserted into the deeper nasal cavity for 5 min. All the EGDs were performed with the patient in the left lateral recumbent position, and without administration of scopolamine butylbromide.

Cardiopulmonary monitoring: Systolic and diastolic blood pressure (BP), pulse rate (PR), and oxygen saturation by pulse oximetry (SpO₂) were measured at the following four points during the endoscopic examination, to measure these parameters at the stabilized condition of patients: (1) baseline; (2) at 2 min and (3) at 5 min after endoscopic intubation; and (4) at the end of the examination. The values of BP, PR and SpO₂ were measured simultaneously with high sensitivity by the newly developed measuring system, Bedside Monitor PetiTelemo DS-7001 (Fukuda Denshi Co. Ltd., Tokyo, Japan). The rate-pressure product (PR × systolic BP/100) was also calculated as shown in previous reports[14,15]. Changes in each value were compared between TN and TO groups.

In the patients treated with PEG tube feeding, we performed periodic PEG tube exchanges during endoscopic observation every 6 mo. For these observations, an endoscopic method, transoral conventional or transnasal small-caliber was selected randomly for each patient by an envelop method, and switched at the next exchange (a crossover design). Changes in cardiopulmonary parameters and markers of inflammation were measured during EGD, and blood leukocyte counts and serum C-reactive protein (CRP) concentrations were measured before and after EGD.

Patients: Between March 2007 and April 2008, 30 patients who were undergoing PEG feeding were enrolled. Reasons for PEG feeding included dysphagia caused by cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, and other conditions. Their PEG tube exchanges were carried out routinely under endoscopic observation every 6 mo, using an instrument (transnasal small-caliber or transoral conventional endoscope) that was assigned randomly to each patient at enrollment. At the next tube exchange 6 mo later, the alternate method was used for each patient. The 30 patients were thereby divided into one initially transnasal, secondarily transoral (TN-TO, n = 15) group, and one initially transoral, secondarily transnasal (TO-TN, n = 15) group. In all of the enrolled patients, a bumper type kit (Ponsky Non-Balloon Replacement Gastrostomy Tube; Bard Limited, Salt Lake City, UT, USA) was used as a PEG tube. Each procedure for the PEG tube exchanges was not done when the patients had infectious diseases such as pneumonia, or urinary or hepato-biliary tract infection. Before PEG tube exchange, chest X-ray examination, urinalysis, and laboratory blood tests including peripheral blood count, inflammatory markers and hepato-biliary enzymes were done to confirm the absence of infectious diseases. In this study, PEG tube exchanges were not performed in patients who showed increases of leukocyte count or CRP and fever elevation before the procedure.

Endoscopic procedure: A single experienced endoscopist (M.Y., as in Study 1) performed all of the examinations, using the same endoscopes and pre-medication regimens as in Study 1. The procedure for PEG tube exchange by transnasal endoscope was similar to that by transoral endoscope. All the EGDs were performed with the patient in the supine position, and without administration of scopolamine butylbromide.

Cardiopulmonary monitoring: During each endoscopy procedure, systolic and diastolic BP, PR, SpO₂ and RPP were determined at the following three points: (1) baseline; (2) at 2 min after endoscopic intubation; and (3) at the end of the examination. Changes in each value were compared between TN and TO endoscopic studies.

Evaluation of inflammatory response: As markers of inflammation, body temperature, leukocyte counts and serum concentrations of CRP were measured. Body temperature was measured before and every 6 h after the endoscopy-guided exchange of PEG tube. Leukocyte counts and CRP were performed routinely before and 3 d after the procedure. If suspicious pneumonia was found, these parameters were examined more frequently. Further examination of pneumonia such as chest X-ray examination and/or computed tomography (CT) was done when respiratory symptoms, fever elevation, and increased leukocyte count and/or CRP were found.

Increased occurrence of aspiration pneumonia: The incidence of aspiration pneumonia was also compared between the TN and TO groups. Pulmonary aspiration was defined by witnessed aspiration or tracheal suctioning of secretions including saliva as shown by previous studies on PEG procedures[16,17]. In patients with post-procedure elevation of inflammation markers and/or fever, aspiration pneumonia was evaluated by chest X-ray examination and/or CT. Pneumonia was diagnosed by the presence of new infiltrates of the lung associated with fever.

Data for each comparison between groups were analyzed using the χ² and Wilcoxon signed rank tests. The latter test was done only when the Friedman test showed significant differences. Categorical data were compared using Student’s t test or, where unequal variances occurred, Welch’s test. P < 0.05 was considered to be significant. All statistical analyses were performed using SPSS version 12.0 (SPSS Japan, Tokyo, Japan).

Ninety-six and 102 elderly patients were analyzed finally as the TN and TO groups, respectively. Twenty-four and 18 patients were excluded since complete data could not be obtained, mainly because of the delay in measurement in the TN and TO groups, respectively. Characteristics of the enrolled patients in each group are shown in Table 1. Mean ages of these patients were 77.0 and 76.7 years, respectively. Total procedure time for EGD was 8.46 ± 4.32 min in the TN group, and 6.03 ± 2.50 min in the TO group. This difference in procedure time was statistically significant (P < 0.001). No serious complications in cardiopulmonary function occurred in this study, although two patients experienced mild epistaxis during pre-medication for transnasal EGD. The baseline cardiopulmonary parameters, RPP and SpO₂, did not show any significant differences (Table 1).

Changes in BP, PR and RPP during endoscopy did not differ significantly between the TN and TO groups, although these parameters tended to increase more in the TO group (Figure 1A). Values for SpO₂ in the TO group decreased significantly during EGD (-0.24% and -0.29% after 2 and 5 min) compared with those in the TN group (+0.24% and +0.18% after 2 and 5 min, P < 0.05). These findings suggested that transoral EGD affects pulmonary function more severely than transnasal EGD does in this group of patients (Figure 1B).

Open in New Tab   Full Size Figure   Download Figure

Figure 1 Time course of changes in RPP and SpO₂ (Study 1). A: RPP tended to increase more in the TO group than in the TN group, although this difference did not reach statistical significance; B: SpO₂ fell significantly at 2 and 5 min after the start of transoral endoscopic examination. Bars show SE. ^aP < 0.05.

We enrolled 30 patients who required PEG feeding: 15 in the TN-TO group and 15 in the TO-TN group. Characteristics of these patients are shown in Tables 2 and 3. Categorical data did not differ significantly between the TN-TO and TO-TN groups. Baseline cardiopulmonary parameters, RPP and SpO₂, did not differ significantly.

Higher values of systolic and diastolic BP were found in the TO group than in the TN group after intubation for endoscopy, but these differences did not reach statistical significance. Values for RPP during and at the end of endoscopy were significantly higher in the TO group (26.8 and 34.6) than those in the TN group (3.1 and 15.2, P < 0.05), as shown in Figure 2A. The SpO₂ also significantly decreased at 2 min after the start of transoral EGD (-0.8%) in comparison with transnasal EGD (-0.1%, P < 0.05) (Figure 2B). Thus, in the bedridden patients with PEG feeding, examined in the supine position, transoral EGD disturbed cardiopulmonary function more strongly than did transnasal EGD.

Open in New Tab   Full Size Figure   Download Figure

Figure 2 Time course of changes in RPP and SpO₂ (Study 2). A: RPP increased significantly more in the TO group than in the TN group. B: SpO₂ fell significantly at 2 min after the start of examination in the TO group. Bars show SE. ^aP < 0.05.

Markers of inflammation also changed significantly in conjunction with endoscopy. Peripheral leukocyte count increased from 6053 ± 1975/L to 6900 ± 3392/L at 3 d after transoral EGD, as shown in Figure 3A (P < 0.001); and CRP values increased from 0.93 ± 0.24 mg/dL to 2.49 ± 0.91 mg/dL (P < 0.001) (Figure 3B). These data also showed statistically significant differences at 3 d after PEG tube exchange between transnasal and transoral EGD (P < 0.001).

Open in New Tab   Full Size Figure   Download Figure

Figure 3 Changes in leukocyte counts (A) and CRP values (B) (Study 2). Counts and CRP increased significantly by the third day after transoral endoscopy (TO), but did not change after transnasal endoscopy (TN). Bars show SE. ^bP < 0.001.

Aspiration pneumonia, possibly caused by the endoscopic examination, was subsequently found in two of 30 patients after transoral EGD. In these two cases, a significant drop in SpO₂ values was found during transoral EGD, and the elevation of inflammation makers (CRP values and leukocyte counts) was also found after the procedure with transoral EGD but not with transnasal EGD. Additionally, the witnessed aspiration or tracheal suctioning of secretions including saliva was observed in these two cases of transoral EGD. Both of these patients recovered after the administration of antibiotics.

Unsedated transnasal small-caliber esophagogastroduodenoscopy (EGD) is often used to examine the upper gastrointestinal tract. Its efficacy for elderly and critically ill patients, however, has not been fully evaluated. To evaluate the tolerability of transnasal EGD for elderly and critically ill bedridden patients, a prospective randomized comparative and a crossover study were undertaken.

Elderly patients, including those who are bedridden, do not frequently gag or choke during transoral conventional EGD. If transoral conventional EGD is safe and comfortable for them, the value of transnasal small-caliber EGD could be limited, because the smaller charge-coupled device in the endoscope may potentially reduce diagnostic accuracy for minute gastric lesions. This is believed to be the first published study concerned with the tolerability and safety of transnasal small-caliber endoscopy for critically ill patients.

Other studies evaluating the tolerability and safety of transnasal endoscopy have focused mainly on younger patients, with a mean age < 50 years old. The data and viewpoints originated from elderly and critically ill patients and have not been published elsewhere.

Significant decreases were observed in SpO₂ saturation during conventional transoral EGD, but not during transnasal small-caliber EGD. Significant increases were also found in the markers of inflammation in bedridden patients after transoral conventional EGD, but not after transnasal small-caliber EGD performed with the patient in the supine position.

This is a prospective study that compared the consequences of using two endoscopic devices (conventional and small caliber) in critically ill patients. The importance of this study is related to the fact that the use of small caliber endoscopes in diagnosis is becoming more common because of its tolerability and lack of sedation.